Literature DB >> 301447

Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.

P Davis, R H Cumming, J Verrier-Jones.   

Abstract

Eighty-nine sera from nineteen patients with systemic lupus erythematosus (SLE) have been studied to determine the relationship between levels of DNA-binding activity, complement consumption and evidence of circulating immune complexes. There was a good correlation between the height of DNA binding, a rising C3i and a reciprocal fall in C3, C4 and CH50 levels. These latter measurements provided useful supplemental information when studied serially. There was a good correlation between the results of the various methods used for the detection of circulating immune complexes, and these were found in almost half the sera with DNA binding over 70%. It is concluded that serial studied of DNA binding, complement levels, and direct tests for immune complexes, may provide valuable information in the management of patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301447      PMCID: PMC1540750     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

Review 1.  Mechanisms of renal injury in systemic lupus erythematosus.

Authors:  D Koffler; H G Kunkel
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965

2.  Native and denatured DNA, cross-linked and palindromic DNA and circular covalently-closed DNA analysed by a sensitive fluorometric procedure.

Authors:  A R Morgan; D E Pulleyblank
Journal:  Biochem Biophys Res Commun       Date:  1974-11-27       Impact factor: 3.575

3.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

4.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

5.  Antibody to nuclear material eluted from isolated spleen vessels in systemic lupus erythematosus.

Authors:  K H Svec; S T Allen
Journal:  Science       Date:  1970-10-30       Impact factor: 47.728

6.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.

Authors:  V Agnello; R J Winchester; H G Kunkel
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

7.  Anticomplementary sera in cutaneous vasculitis.

Authors:  J J Cream
Journal:  Br J Dermatol       Date:  1973-12       Impact factor: 9.302

8.  Complement metabolism in rheumatoid arthritis. I. Longitudinal studies.

Authors:  J M Versey; J R Hobbs; P J Holt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

9.  Formaldehyde as a probe of DNA structure. I. Reaction with exocyclic amino groups of DNA bases.

Authors:  J D McGhee; P H von Hippel
Journal:  Biochemistry       Date:  1975-03-25       Impact factor: 3.162

10.  Plasmapheresis in the management of acute systemic lupus erythematosus?

Authors:  J V Jones; R H Cumming; R C Bucknall; C M Asplin
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

View more
  21 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.

Authors:  Ona Bloom; Kai Fan Cheng; Kai Fen Cheng; Mingzhu He; Angelos Papatheodorou; Bruce T Volpe; Betty Diamond; Yousef Al-Abed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

3.  Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy.

Authors:  F Furukawa; K Sekita; Y Hamashima; M Ozaki; S Imamura
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

4.  Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.

Authors:  E R Richens; C M Thorp; P W Bland; N D Hall
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

5.  The effect of chronic daily cyclophosphamide administration on established antibody responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Serum C4 concentration in the monitoring of systemic lupus erythematosus: requirement for C4 allotyping.

Authors:  G Uko; F T Christiansen; R L Dawkins
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.

Authors:  K Narayanan; V Marwaha; K Shanmuganandan; S Shankar
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.

Authors:  A J Swaak; J Groenwold; A Hannema; C E Hack
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

9.  Peripheral blood and mesenteric lymph node lymphocytes in Crohn's disease.

Authors:  E R Richens; C M Thorp; P W Bland; K R Gough
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

10.  Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.

Authors:  Olivier C Meyer; Pascale Nicaise-Roland; Nolwenn Cadoudal; Sabine Grootenboer-Mignot; Elisabeth Palazzo; Gilles Hayem; Philippe Dieudé; Sylvie Chollet-Martin
Journal:  Arthritis Res Ther       Date:  2009-06-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.